Physician profile
Atef Wasef
NPI 1730140542
$3,568.16
in general payments reported to CMS, 2019-2025
21 companies · $1,551 in 2025
The $1,551 reported for 2025 was more than what 77% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $24.48 · 2021: $24.16 · 2022: $75.17 · 2023: $191 · 2024: $1,569 · 2025: $1,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,500 · Travel and Lodging: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,500.41 |
| Travel and Lodging | $810.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $940.67 | 2024 | |
| Medtronic, INC. | $791.46 | 2022-2025 | Intellis Adaptivestim, Synchromedii |
| Abbvie INC. | $475.33 | 2024-2025 | |
| Boston Scientific Corporation | $237.48 | 2019-2025 | Intracept, General - Pain Management |
| Saluda Medical Americas, INC. | $216.27 | 2025 | Evoke |
| Abbott Laboratories | $160.26 | 2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $126.27 | 2024-2025 | Relistor |
| Mml US, INC. | $123.50 | 2025 | Reactiv8 |
| Protega Pharmaceutials INC | $81.05 | 2024-2025 | Roxybond |
| Nevro Corp. | $75.77 | 2020-2023 | Senza |
| Scilex Pharmaceuticals INC. | $61.02 | 2019-2025 | |
| Nalu Medical, INC. | $55.74 | 2025 | Nalu Neurostimulation System |
| Pfizer INC. | $51.45 | 2019 | |
| Spinal Simplicity, LLC | $41.09 | 2024 | Ha Minuteman G3-R |
| Almatica Pharma LLC | $24.16 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $23.54 | 2024 | |
| Globus Medical, INC. | $22.35 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $21.42 | 2023 | Iovera, Zilretta, Exparel |
| Daiichi Sankyo INC. | $16.96 | 2019 | |
| Foundation Fusion Solutions, LLC | $11.49 | 2024 | |
| Electronic Waveform Lab, INC. | $10.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atef Wasef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.